Press Releases

Transcept in the News

05/14/12
Transcept Pharmaceuticals Reports First Quarter 2012 Financial Results

05/09/12
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences


Shareholder Tools

Briefcase        RSS        Email Alerts
All Releases
05/14/12 Transcept Pharmaceuticals Reports First Quarter 2012 Financial Results PDF Add to Briefcase
05/09/12 Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences PDF Add to Briefcase
05/07/12 Transcept Pharmaceuticals to Report First Quarter 2012 Financial Results and Host Conference Call on May 14, 2012 PDF Add to Briefcase
04/26/12 Transcept Prices Public Offering of Common Stock PDF Add to Briefcase
04/25/12 Transcept Announces Proposed Public Offering PDF Add to Briefcase
04/16/12 Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference PDF Add to Briefcase
04/10/12 Transcept Pharmaceuticals Announces the Promotion of Thomas Soloway to Executive Vice President and Chief Operating Officer PDF Add to Briefcase
04/05/12 Transcept Pharmaceuticals Announces National Product Launch of Intermezzo® by Purdue Pharma L.P. PDF Add to Briefcase
03/14/12 Transcept Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results PDF Add to Briefcase
03/07/12 Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2011 Financial Results and Host Conference Call on March 14, 2012 PDF Add to Briefcase
02/29/12 Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences PDF Add to Briefcase
02/07/12 Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences PDF Add to Briefcase
12/21/11 Transcept Pharmaceuticals Receives $10 Million Milestone Payment from Purdue for Listing of Intermezzo Formulation Patents in FDA Orange Book PDF Add to Briefcase
12/08/11 Transcept Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011 PDF Add to Briefcase
11/30/11 Transcept Pharmaceuticals to Host Conference Call to Discuss Purdue's Exercise of Option to Commercialize Intermezzo® in the United States PDF Add to Briefcase
11/30/11 Transcept Pharmaceuticals Announces Purdue's Exercise of Option to Commercialize Intermezzo® in the United States PDF Add to Briefcase
11/23/11 Transcept Pharmaceuticals Announces FDA Approval of Intermezzo® (zolpidem tartrate sublingual tablet) C-IV For Use as Needed for the Treatment of Insomnia When a Middle-of-the-Night Awakening is Followed by Difficulty Returning to Sleep PDF Add to Briefcase
11/23/11 Transcept Pharmaceuticals to Host Conference Call to Discuss FDA Approval of Intermezzo® PDF Add to Briefcase
11/10/11 Transcept Pharmaceuticals Reports Third Quarter 2011 Financial Results PDF Add to Briefcase
11/02/11 Transcept Pharmaceuticals to Report Third Quarter 2011 Financial Results and Host Conference Call on November 10, 2011 PDF Add to Briefcase
Showing 1-20 of 110 Page: 1 2 3 ... 6  Next 20
=add release to Briefcase